This study investigated the phytochemicals in Phyla nodiflora leaf extracts and identified n-Hexadecanoic acid, stigmasterol, and beta-sitosterol as promising drug candidates for diabetes, alopecia, cancer, and anti-diuresis, advocating further research into these compounds.
December 2024 in “Plant Science Today” This study investigated the therapeutic potential of phytochemicals from Phyla nodiflora, identifying 50 bioactive compounds through GC-MS analysis. Among them, n-hexadecanoic acid, stigmasterol, and beta-sitosterol showed promise in molecular docking studies as drug candidates for diabetes, alopecia, cancer, and anti-diuresis.
1 citations
,
February 2017 in “Journal of pharmacology & clinical research” This study found that topical gel formulations containing extracts of Eclipta alba and Lippia nodiflora significantly increased hair growth in black mice over 30 days, with a combination of both extracts showing greater effectiveness than either alone.
6 citations
,
August 2024 in “The Journal of Dermatology” In this study, ozenoxacin was found to inhibit sebum production in insulin- and 5α-DHT-differentiated hamster sebocytes in a dose-dependent manner, suggesting potential benefits in acne management by combining antimicrobial activity against C. acnes with reduced sebum production.
October 2023 in “International journal of research in Ayurveda and pharmacy” This review found that the ingredients of Keedari thailam, a traditional Siddha formulation used for alopecia areata, exhibit antimicrobial, anti-inflammatory, and other pharmacological activities, suggesting potential therapeutic benefits according to recent research and Siddha literature.